{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,4,22]],"date-time":"2026-04-22T17:16:27Z","timestamp":1776878187251,"version":"3.51.2"},"reference-count":41,"publisher":"MDPI AG","issue":"7","license":[{"start":{"date-parts":[[2025,6,27]],"date-time":"2025-06-27T00:00:00Z","timestamp":1750982400000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Veterinary Sciences"],"abstract":"<jats:p>Urothelial carcinoma (UC) is one of the most frequent tumors in dogs. Besides cytology, histology, and testing for a BRAF mutation, non-invasive biomarkers would benefit the early detection and therapy of UC. This study aimed to compare the detectability of miRNAs in urine sediment and supernatant and to assess their potential as biomarkers for UC. The study involved two phases with 47 canine samples in total; in a pilot trial, ten different miRNAs (miR-16, 21, 103b, 106b, 146, 155, 182, 221, 222, and 375) were isolated from the urine sediments and supernatants from seven healthy control dogs and seven dogs with UC. In a further step, eight miRNAs were isolated from urine sediments from 18 healthy dogs, 11 dogs with purulent cystitis, and 18 dogs with UC. The detectability of miRNAs was improved when isolated from the urine sediment compared with the supernatant. MiR-16 was not deregulated, and miR-106b showed significantly lower expression in cystitis compared with the control. Lower copy numbers were seen for miR-21, 182, 221, and 222 in cystitis cases compared with the controls and UC, respectively. Deregulation was observed for miR-155 and miR-375 between all three groups. A panel including miR-182, 221, 222, 155, and 375 has the potential to discriminate among all three groups in a two-step approach.<\/jats:p>","DOI":"10.3390\/vetsci12070621","type":"journal-article","created":{"date-parts":[[2025,7,1]],"date-time":"2025-07-01T05:28:28Z","timestamp":1751347708000},"page":"621","update-policy":"https:\/\/doi.org\/10.3390\/mdpi_crossmark_policy","source":"Crossref","is-referenced-by-count":2,"title":["Utility of Urinary miRNA Biomarkers for Canine Urothelial Carcinoma Diagnostics"],"prefix":"10.3390","volume":"12","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-1547-0713","authenticated-orcid":false,"given":"Alexandra","family":"Kehl","sequence":"first","affiliation":[{"name":"LABOKLIN GmbH&CO.KG, 97768 Bad Kissingen, Germany"},{"name":"School of Medicine, Institute of Pathology, Technical University of Munich, 81675 M\u00fcnchen, Germany"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-4601-1480","authenticated-orcid":false,"given":"Heike","family":"Aupperle-Lellbach","sequence":"additional","affiliation":[{"name":"LABOKLIN GmbH&CO.KG, 97768 Bad Kissingen, Germany"},{"name":"School of Medicine, Institute of Pathology, Technical University of Munich, 81675 M\u00fcnchen, Germany"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-6162-7515","authenticated-orcid":false,"given":"Maria","family":"Brockmann","sequence":"additional","affiliation":[{"name":"LABOKLIN GmbH&CO.KG, 97768 Bad Kissingen, Germany"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Anna-Lena van de","family":"Weyer","sequence":"additional","affiliation":[{"name":"LABOKLIN GmbH&CO.KG, 97768 Bad Kissingen, Germany"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Marielle","family":"Appenzeller","sequence":"additional","affiliation":[{"name":"LABOKLIN GmbH&CO.KG, 97768 Bad Kissingen, Germany"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-7269-5433","authenticated-orcid":false,"given":"Katja","family":"Steiger","sequence":"additional","affiliation":[{"name":"School of Medicine, Institute of Pathology, Technical University of Munich, 81675 M\u00fcnchen, Germany"}],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"1968","published-online":{"date-parts":[[2025,6,27]]},"reference":[{"key":"ref_1","doi-asserted-by":"crossref","first-page":"47","DOI":"10.1016\/S1078-1439(99)00006-X","article-title":"Naturally-occurring canine transitional cell carcinoma of the urinary bladder A relevant model of human invasive bladder cancer","volume":"5","author":"Knapp","year":"2000","journal-title":"Urol. Oncol."},{"key":"ref_2","doi-asserted-by":"crossref","first-page":"59","DOI":"10.1093\/ilar\/ilu017","article-title":"Domestic dogs and cancer research: A breed-based genomics approach","volume":"55","author":"Davis","year":"2014","journal-title":"ILAR J."},{"key":"ref_3","doi-asserted-by":"crossref","first-page":"145","DOI":"10.1111\/j.1939-1676.1992.tb00330.x","article-title":"Canine bladder and urethral tumors: A retrospective study of 115 cases (1980\u20131985)","volume":"6","author":"Norris","year":"1992","journal-title":"J. Vet. Int. Med."},{"key":"ref_4","doi-asserted-by":"crossref","unstructured":"Mochizuki, H., Shapiro, S.G., and Breen, M. (2015). Detection of BRAF Mutation in Urine DNA as a Molecular Diagnostic for Canine Urothelial and Prostatic Carcinoma. PLoS ONE, 10.","DOI":"10.1371\/journal.pone.0144170"},{"key":"ref_5","doi-asserted-by":"crossref","first-page":"764","DOI":"10.1177\/0300985815614975","article-title":"Detection of Copy Number Imbalance in Canine Urothelial Carcinoma with Droplet Digital Polymerase Chain Reaction","volume":"53","author":"Mochizuki","year":"2016","journal-title":"Vet. Pathol."},{"key":"ref_6","doi-asserted-by":"crossref","first-page":"289","DOI":"10.15654\/TPK-180554","article-title":"Diagnostische Aussagekraft der BRAF-Mutation V595E in Urinproben, Ausstrichen und Bioptaten beim kaninen \u00dcbergangszellkarzinom","volume":"46","author":"Grassinger","year":"2018","journal-title":"Tierarztl. Prax. Ausg. K Kleintiere. Heimtiere."},{"key":"ref_7","doi-asserted-by":"crossref","first-page":"281","DOI":"10.1016\/S0092-8674(04)00045-5","article-title":"MicroRNAs","volume":"116","author":"Bartel","year":"2004","journal-title":"Cell"},{"key":"ref_8","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/j.ydbio.2006.08.028","article-title":"microRNAs as oncogenes and tumor suppressors","volume":"302","author":"Zhang","year":"2007","journal-title":"Dev. Biol."},{"key":"ref_9","doi-asserted-by":"crossref","first-page":"35","DOI":"10.1007\/s40139-017-0123-0","article-title":"MicroRNAs in Cancer: Challenges and opportunities in early detection, disease monitoring, and therapeutic agents","volume":"5","author":"Chatterjee","year":"2017","journal-title":"Curr. Pathobiol. Rep."},{"key":"ref_10","doi-asserted-by":"crossref","first-page":"287","DOI":"10.1146\/annurev-pathol-012513-104715","article-title":"MicroRNAs in cancer","volume":"9","author":"Garofalo","year":"2014","journal-title":"Annu. Rev. Pathol."},{"key":"ref_11","doi-asserted-by":"crossref","first-page":"2087","DOI":"10.1111\/j.1349-7006.2010.01650.x","article-title":"Circulating microRNA in body fluid: A new potential biomarker for cancer diagnosis and prognosis","volume":"101","author":"Kosaka","year":"2010","journal-title":"Cancer Sci."},{"key":"ref_12","first-page":"265","article-title":"MicroRNA Significance in Cancer: An Updated Review on Diagnostic, Prognostic, and Therapeutic Perspectives","volume":"35","author":"Singh","year":"2024","journal-title":"EJIFCC"},{"key":"ref_13","doi-asserted-by":"crossref","unstructured":"Sohel, M.M.H. (2020). Circulating microRNAs as biomarkers in cancer diagnosis. Life Sci., 248.","DOI":"10.1016\/j.lfs.2020.117473"},{"key":"ref_14","doi-asserted-by":"crossref","unstructured":"Xinyi, L., Jinlong, L., and Bin, Z. (2025). Low-Invasive Biomarkers of Canine Mammary Tumours. Vet. Med. Sci., 11.","DOI":"10.1002\/vms3.70280"},{"key":"ref_15","doi-asserted-by":"crossref","first-page":"310","DOI":"10.1111\/vco.13057","article-title":"Classification and Prognostication of B-Cell and T-Cell Multicentric Lymphoma in Dogs Using Serum MicroRNAs","volume":"23","author":"Ludwig","year":"2025","journal-title":"Vet. Comp. Oncol."},{"key":"ref_16","doi-asserted-by":"crossref","unstructured":"Varvil, M.S., Bailey, T., Dhawan, D., Knapp, D.W., Ramos-Vara, J.A., and Dos Santos, A.P. (2022). The miRNome of canine invasive urothelial carcinoma. Front. Vet. Sci., 9.","DOI":"10.3389\/fvets.2022.945638"},{"key":"ref_17","doi-asserted-by":"crossref","first-page":"1626","DOI":"10.2460\/ajvr.73.10.1626","article-title":"Expression of microRNAs in urinary bladder samples obtained from dogs with grossly normal bladders, inflammatory bladder disease, or transitional cell carcinoma","volume":"73","author":"Vinall","year":"2012","journal-title":"Am. J. Vet. Res."},{"key":"ref_18","doi-asserted-by":"crossref","unstructured":"Kent, M.S., Zwingenberger, A., Westropp, J.L., Barrett, L.E., Durbin-Johnson, B.P., Ghosh, P., and Vinall, R.L. (2017). MicroRNA profiling of dogs with transitional cell carcinoma of the bladder using blood and urine samples. BMC Vet. Res., 13.","DOI":"10.1186\/s12917-017-1259-1"},{"key":"ref_19","doi-asserted-by":"crossref","unstructured":"Karttunen, J., Kalmar, L., Grant, A., Ying, J., Stewart, S.E., Wang, X., Frankl, F.K., and Williams, T. (2024). miR-182, miR-221 and miR-222 are potential urinary extracellular vesicle biomarkers for canine urothelial carcinoma. Sci. Rep., 14.","DOI":"10.1038\/s41598-024-69070-7"},{"key":"ref_20","doi-asserted-by":"crossref","first-page":"573","DOI":"10.1002\/pros.23295","article-title":"Exosomal and Non-Exosomal Urinary miRNAs in Prostate Cancer Detection and Prognosis","volume":"77","author":"Foj","year":"2017","journal-title":"Prostate"},{"key":"ref_21","doi-asserted-by":"crossref","first-page":"121","DOI":"10.31557\/APJCP.2023.24.1.121","article-title":"Urine micro-RNA signature as a potential non-invasive diagnostic biomarker in bladder cancer","volume":"24","author":"Mamdouh","year":"2023","journal-title":"Asian Pac. J. Cancer Prev."},{"key":"ref_22","doi-asserted-by":"crossref","first-page":"88","DOI":"10.1002\/pros.23714","article-title":"miR-21-5p, miR-141-3p, and miR-205-5p levels in urine-promising biomarkers for the identification of prostate and bladder cancer","volume":"79","author":"Ghorbanmehr","year":"2019","journal-title":"Prostate"},{"key":"ref_23","doi-asserted-by":"crossref","unstructured":"Lee, H., Kang, S.J., Lee, J., Park, K.H., and Rhee, W.J. (2022). Isolation and Characterization of Urinary Extracellular Vesicles from Healthy Donors and Patients with Castration-Resistant Prostate Cancer. Int. J. Mol. Sci., 23.","DOI":"10.3390\/ijms23137134"},{"key":"ref_24","doi-asserted-by":"crossref","first-page":"24668","DOI":"10.18632\/oncotarget.14969","article-title":"MiR-21-5p in urinary extracellular vesicles is a novel biomarker of urothelial carcinoma","volume":"8","author":"Matsuzaki","year":"2017","journal-title":"Oncotarget"},{"key":"ref_25","doi-asserted-by":"crossref","first-page":"70","DOI":"10.1016\/j.ejps.2016.10.008","article-title":"Extracellular vesicles as a source for non-invasive biomarkers in bladder cancer progression","volume":"98","author":"Andreu","year":"2017","journal-title":"Eur. J. Pharm. Sci."},{"key":"ref_26","doi-asserted-by":"crossref","unstructured":"Lin, J.-T., and Tsai, K.-W. (2021). Circulating miRNAs Act as Diagnostic Biomarkers for Bladder Cancer in Urine. Int. J. Mol. Sci., 22.","DOI":"10.3390\/ijms22084278"},{"key":"ref_27","doi-asserted-by":"crossref","first-page":"e493","DOI":"10.1016\/j.clgc.2016.04.002","article-title":"Expression Level of Urinary MicroRNA-146a-5p Is Increased in Patients with Bladder Cancer and Decreased in Those After Transurethral Resection","volume":"14","author":"Sasaki","year":"2016","journal-title":"Clin. Genitourin. Cancer"},{"key":"ref_28","doi-asserted-by":"crossref","first-page":"2725","DOI":"10.1007\/s00432-019-03035-6","article-title":"MicroRNAs in tumor samples and urinary extracellular vesicles as a putative diagnostic tool for muscle-invasive bladder cancer","volume":"145","author":"Baumgart","year":"2019","journal-title":"J. Cancer Res. Clin. Oncol."},{"key":"ref_29","doi-asserted-by":"crossref","first-page":"419","DOI":"10.1021\/acs.analchem.3c04461","article-title":"Smartphone-Based Fluorescent Profiling of Quaternary MicroRNAs in Urine for Rapid Diagnosis of Urological Cancers Using a Multiplexed Isothermal Exponential Amplification Reaction","volume":"96","author":"Yao","year":"2024","journal-title":"Anal. Chem."},{"key":"ref_30","doi-asserted-by":"crossref","first-page":"3255","DOI":"10.18632\/oncotarget.6487","article-title":"Direct quantitative detection for cell-free miR-155 in urine: A potential role in diagnosis and prognosis for non-muscle invasive bladder cancer","volume":"7","author":"Zhang","year":"2016","journal-title":"Oncotarget"},{"key":"ref_31","doi-asserted-by":"crossref","first-page":"1","DOI":"10.2460\/ajvr.24.05.0150","article-title":"A review of the current standing of microRNA expression in canine urothelial carcinoma","volume":"85","author":"Varvil","year":"2024","journal-title":"Am. J. Vet. Res."},{"key":"ref_32","doi-asserted-by":"crossref","unstructured":"Benning, L., Robinson, S., Follo, M., Heger, L.A., Stallmann, D., Duerschmied, D., Bode, C., Ahrens, I., and Hortmann, M. (2018). Digital PCR for Quantifying Circulating MicroRNAs in Acute Myocardial Infarction and Cardiovascular Disease. J. Vis. Exp., 137.","DOI":"10.3791\/57950-v"},{"key":"ref_33","doi-asserted-by":"crossref","first-page":"449","DOI":"10.1111\/vco.12790","article-title":"BRAF mutation status and its prognostic significance in 79 canine urothelial carcinomas: A retrospective study (2006\u20132019)","volume":"20","author":"Gedon","year":"2022","journal-title":"Vet. Comp. Oncol."},{"key":"ref_34","doi-asserted-by":"crossref","unstructured":"Aveta, A., Cilio, S., Contieri, R., Spena, G., Napolitano, L., Manfredi, C., Franco, A., Crocerossa, F., Cerrato, C., and Ferro, M. (2023). Urinary MicroRNAs as Biomarkers of Urological Cancers: A Systematic Review. Int. J. Mol. Sci., 24.","DOI":"10.20944\/preprints202305.1974.v1"},{"key":"ref_35","doi-asserted-by":"crossref","first-page":"70","DOI":"10.1177\/10406387231211908","article-title":"Canine urothelial carcinoma: A pilot study of microRNA detection in formalin-fixed, paraffin-embedded tissue samples and in normal urine","volume":"36","author":"Varvil","year":"2024","journal-title":"J. Vet. Diagn. Investig."},{"key":"ref_36","doi-asserted-by":"crossref","first-page":"623","DOI":"10.2217\/bmm.13.44","article-title":"Stability of miRNA in human urine supports its biomarker potential","volume":"7","author":"Mall","year":"2013","journal-title":"Biomark. Med."},{"key":"ref_37","doi-asserted-by":"crossref","first-page":"1871","DOI":"10.3892\/ijo.2012.1622","article-title":"Cell-free microRNAs in urine as diagnostic and prognostic biomarkers of bladder cancer","volume":"41","author":"Yun","year":"2012","journal-title":"Int. J. Oncol."},{"key":"ref_38","doi-asserted-by":"crossref","unstructured":"Roest, H.P., IJzermans, J.N.M., and van der Laan, L.J.W. (2021). Evaluation of RNA isolation methods for microRNA quantification in a range of clinical biofluids. BMC Biotechnol., 21.","DOI":"10.1186\/s12896-021-00706-6"},{"key":"ref_39","doi-asserted-by":"crossref","unstructured":"Capuano, C., Moccia, V., Molinari, A., Torrigiani, F., Ferro, L., Ferraresso, S., Bonsembiante, F., Leo, C., and Zappulli, V. (2024). Free circulating versus extracellular vesicle-associated microRNA expression in canine T-cell lymphoma. Front. Vet. Sci., 11.","DOI":"10.3389\/fvets.2024.1461506"},{"key":"ref_40","doi-asserted-by":"crossref","unstructured":"Nobrega, M., Reis, M.B.D., Souza, M.F.d., Furini, H.H., Costa Brand\u00e3o Berti, F., Souza, I.L.M., Mingorance Carvalho, T., Zanata, S.M., Fuganti, P.E., and Malheiros, D. (2025). Comparative analysis of extracellular vesicles miRNAs (EV-miRNAs) and cell-free microRNAs (cf-miRNAs) reveals that EV-miRNAs are more promising as diagnostic and prognostic biomarkers for prostate cancer. Gene, 939.","DOI":"10.1016\/j.gene.2024.149186"},{"key":"ref_41","doi-asserted-by":"crossref","first-page":"1637","DOI":"10.1111\/jvim.15250","article-title":"Sensitivity and specificity of microRNA-122 for liver disease in dogs","volume":"32","author":"Oosthuyzen","year":"2018","journal-title":"J. Vet. Intern. Med."}],"container-title":["Veterinary Sciences"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.mdpi.com\/2306-7381\/12\/7\/621\/pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,10,9]],"date-time":"2025-10-09T18:00:15Z","timestamp":1760032815000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.mdpi.com\/2306-7381\/12\/7\/621"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,6,27]]},"references-count":41,"journal-issue":{"issue":"7","published-online":{"date-parts":[[2025,7]]}},"alternative-id":["vetsci12070621"],"URL":"https:\/\/doi.org\/10.3390\/vetsci12070621","relation":{},"ISSN":["2306-7381"],"issn-type":[{"value":"2306-7381","type":"electronic"}],"subject":[],"published":{"date-parts":[[2025,6,27]]}}}